• Blog
  • Sickle Cell Market Growth Analysis | 2023-2028

    Sickle Cell Market Growth Analysis | 2023-2028

     Sickle Cell Market Growth Analysis | 2023-2028
    Report code - SRHL328 Delivery - 2 Weeks
    Sickle Cell Market Size, Share, Trends, Dynamics, Forecast, & Growth Analysis - 2023-2 See more...

    Market Insights

    The sickle cell market was estimated at USD 2.81 billion in 2022 and is likely to grow at a CAGR of 14.40% during 2023-2028 to reach USD 6.33 billion in 2028.

    Sickle-Cell-Market-Insights

    Want to know more about the market scope? Register Here.

    What is sickle cell?

    Sickle cell anemia is defined as an inherited red blood cell disorder in which the number of healthy red blood cells that carry oxygen throughout the body is not sufficient. The red blood cells are shaped like sickles or crescent moons in the person having sickle cell disease. These cells can get stuck in the small blood vessels and thus, slow or block blood flow and oxygen.

    COVID-19 Impact

    The COVID-19 outbreak posed significant challenges to the healthcare system across geographies. It affected the growth of the sickle cell market negatively as patients postponed their appointments due to a rapid surge in COVID-19 cases across geographies. Also, supply chain disruptions due to the imposition of lockdown affected the market growth further.

    Sickle Cell Market Report Overview

    Market Size in 2028

    USD 6.33 billion

    Market Size in 2022

    USD 2.81 billion

    Market Growth (2023-2028)

    CAGR of 14.40%

    Base Year of Study

    2022

    Trend Period

    2017-2021

    Forecast Period

    2023-2028

    Market Dynamics

    The global market growth is primarily driven by the increasing prevalence of sickle cell traits among patients.

    • The market players are continuously emphasizing on development of technologically advanced solutions to treat the disease and reduce the mortality rate of patients suffering from sickle cell disease.
    • Increasing clinical trials using various therapies is likely to create lucrative opportunities for the players operating in the global market. However, the high treatment cost is likely to pose a hindrance to the market growth.

    Sickle-Cell-Market-Dynamics

    Want to have a closer look at this market report? Click Here.

    Segment Analysis

    By End User Type

    Based on end users, the market has been divided into hospital, clinic, and home healthcare.

    • The hospitals segment accounted for the largest market share of more than 30% in 2022.
    • The segment growth can be attributed to the increasing number of people suffering from sickle disease in the hospitals.
    • The clinic segment is projected to register the highest growth during the review period.

    Regional Insights

    The market in North America accounted for the largest share in 2022 and is projected to register significant growth during the review period.

    • The regional market growth can be attributed to the availability of the required infrastructure and technologies to treat patients the sickle disease.
    • The market in the Asia-Pacific region is projected to register the fastest growth rate on account of rising consumer awareness and advancement in healthcare infrastructure in developing countries.

    Sickle-Cell-Market-Regional-Insights

    Know the high-growth countries in this report. Click here.

    Critical Questions Answered in the Report

    • What are the key trends in the global market?
    • How the market (and its various sub-segments) has grown in the last five years and what would be the growth rate in the next five years?
    • What is the impact of COVID-19 on the global market?
    • What are the key strategies adopted by the major vendors to lead in the market?
    • What is the market share of the top vendors?

    Market Segmentation

    This report studies the market covering a period of 12 years of trend and forecast. The report provides detailed insights into the market dynamics to enable informed business decision-making and growth strategy formulation based on the opportunities present in the market.

    The sickle cell market is segmented into the following categories.

    By Therapy Type

    • Bone Marrow Transplant
    • Medications
    • Blood Transfusion
    • Gene Therapy

    By End-User Type

    • Hospital
    • Clinic
    • Home Healthcare

    By Region

    • North America (Country Analysis: the USA, Canada, and Mexico)
    • Europe (Country Analysis: Germany, France, the UK, Russia, Spain, and Rest of Europe)
    • Asia-Pacific (Country Analysis: China, Japan, India, South Korea, and Rest of Asia-Pacific)
    • Rest of the World (Sub-Region Analysis: Latin America, the Middle East, and Others)

    Sickle-Cell-Market-Segmentation

    Click Here, to learn the market segmentation details.

    Key Players

    Key players operating in the global market are-

    • Bluebird bio, Inc. (The U.S),
    • Eli Lilly and Company (The U.S),
    • Gilead Sciences, Inc. (The U.S),
    • Merck & Co., Inc. (The U.S),
    • Novartis International AG (Switzerland),
    • Sanofi S.A. (France),
    • Baxter International Inc. (The U.S),
    • Bristol-Myers Squibb  (The U.S),
    • Global Blood Therapeutics (The U.S),
    • Johnson & Johnson (The U.S),
    • Mast Therapeutics (The U.S), and
    • Pfizer, Inc. (The U.S).

    Target Audience

    • Sickle cell distributors
    • Sickle cell suppliers
    • Sickle cell manufacturers
    • Logistics organizations
    • Government bodies

    Research Methodology

    This report offers high-quality insights and is the outcome of a detailed research methodology comprising extensive secondary research, rigorous primary interviews with industry stakeholders, and validation and triangulation with Stratview Research’s internal database and statistical tools.

    More than 1,000 authenticated secondary sources, such as company annual reports, fact books, press releases, journals, investor presentations, white papers, patents, and articles have been leveraged to gather the data.

    We conducted more than 10 detailed primary interviews with the market players across the value chain in all four regions and with industry experts to obtain both qualitative and quantitative insights.

    Report Features

    This report provides market intelligence in the most comprehensive way. The report structure has been kept such that it offers maximum business value. It provides critical insights into the market dynamics and will enable strategic decision-making for the existing market players as well as those willing to enter the market.

    What Deliverables Will You Get in this Report?

    Key questions this report answers

    Relevant contents in the report

    How big is the sales opportunity?

    In-depth Analysis of the Sickle Cell Market

    How lucrative is the future?

    Market forecast and trend data and emerging trends

    Which regions offer the best sales opportunities?

    Global, regional, and country-level historical data and forecasts

    Which are the most attractive market segments?

    Market Segment Analysis and Forecast

    Which are the top players and their market positioning?

    Competitive landscape analysis, Market share analysis

    How complex is the business environment?

    Porter’s five forces analysis, PEST analysis, Life cycle analysis

    What are the factors affecting the market?

    Drivers & challenges

    Will I get the information on my specific requirements?

    10% free customization

    Report Customization Options

    With this detailed report, Stratview Research offers one of the following free customization options to our respectable clients:

    Company Profiling

    • Detailed profiling of additional market players (up to 3 players)
    • SWOT analysis of key players (up to 3 players)

    Market Segmentation

    • Current market segmentation of any one of the therapy types by end-user type.

    Competitive Benchmarking

    • Benchmarking of key players on the following parameters: Product portfolio, geographical reach, regional presence, and strategic alliances.

    Custom Research: Stratview Research offers custom research services across sectors. In case of any custom research requirement related to market assessment, competitive benchmarking, sourcing and procurement, target screening, and others, please send your inquiry to sales@stratviewresearch.com.

    Frequently Asked Questions (FAQs)

    Sickle cell anemia is defined as an inherited red blood cell disorder in which the number of healthy red blood cells that carry oxygen throughout the body is not sufficient. The red blood cells are shaped like sickles or crescent moons in the person having sickle cell disease. These cells can get stuck in the small blood vessels and thus, slow or block blood flow and oxygen.

    The sickle cell market was estimated at USD 2.81 billion in 2022.

    The sickle cell market is likely to reach USD 6.33 billion in 2028.

    The sickle cell market is likely to grow at a CAGR of 14.40% during 2023-2028.

    Bluebird bio, Inc. (The U.S), Eli Lilly and Company (The U.S), Gilead Sciences, Inc. (The U.S), Merck & Co., Inc. (The U.S), Novartis International AG (Switzerland), Sanofi S.A. (France), Baxter International Inc. (The U.S), Bristol-Myers Squibb (The U.S), Global Blood Therapeutics (The U.S), Johnson & Johnson (The U.S), Mast Therapeutics (The U.S) and Pfizer, Inc. (The U.S) are among the key players in the market.

    North America accounted for the largest share in 2022 and is projected to register significant growth.

    Asia-Pacific is expected to register the fastest growth rate in the market in the coming years.

    The increasing prevalence of sickle cell traits among patients, and increasing clinical trials using various therapies are the factors driving the growth of the market.